Lung cancer patients' perceptions of informed consent documents

Patient Education and Counseling

Volumn 73, Issue 2, 2008, Pages 313-317

  Sand, Kari ^a   Loge, Jon Håvard ^a,b   Berger, Ola ^a   Grønberg, Bjørn Henning ^a,c   Kaasa, Stein ^a,c  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

Clinical trials; Communication; Consent forms; Ethics; Lung neoplasms

Indexed keywords

CARBOPLATIN; GEMCITABINE; PEMETREXED;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; MEDICAL DOCUMENTATION; MEDICAL INFORMATION; PATIENT ASSESSMENT; PERCEPTION; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; SEMI STRUCTURED INTERVIEW;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; INFORMED CONSENT; LUNG NEOPLASMS; MALE; MIDDLE AGED; NORWAY; PALLIATIVE CARE; PATIENT SATISFACTION; PATIENT SELECTION;

EID: 53049105097     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pec.2008.06.011     Document Type: Article

References (20)

1. World Medical Association. The Declaration of Helsinki. http://www.wma.net/e/policy/b3.htm.
2. Joffe S., Cook E.F., Cleary P.D., Clark J.W., and Weeks J.C. Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet 358 (2001) 1772-1777
3. Schultz A.L., Pardee G., and Ensinck J.W. Are research subjects really informed?. West J Med 123 (1975) 76-80
4. Estey A., Wilkin G., and Dossetor J. Are research subjects able to retain the information they are given during the consent process. Health Law Rev 3 (1994) 37-41
5. Griffin J.M., Struve J.K., Collins D., Liu A., Nelson D.B., and Bloomfield H.E. Long term clinical trials: how much information do participants retain from the informed consent process?. Contemp Clin Trials 27 (2006) 441-448
6. Itoh K., Sasaki Y., Fujii H., Ohtsu T., Wakita H., Igarashi T., et al. Patients in phase I trials of anti-cancer agents in Japan: motivation, comprehension and expectations. Br J Cancer 76 (1997) 107-113
7. Barrett R. Quality of informed consent: measuring understanding among participants in oncology clinical trials. Oncol Nurs Forum 32 (2005) 751-755
8. Appelbaum P.S., Lidz C.W., and Grisso T. Therapeutic misconception in clinical research: frequency and risk factors. IRB 26 (2004) 1-8
9. Grønberg B., Bremnes R., Aasebø U., Brunsvig P., Fløtten Ø., Hjelde H., et al. Pemetrexed + carboplatin versus gemcitabine + carboplatin in the treatment of stage IIIB/IV non-small cell lung cancer. J Clin Oncol 25 (2007) 7517
10. Severinsson E. Moral stress and burnout: qualitative content analysis. Nurs Health Sci 5 (2003) 59-66
11. Ydreborg B., Ekberg K., and Nilsson K. Swedish social insurance officers' experiences of difficulties in assessing applications for disability pensions-an interview study. BMC Public Health 7 (2007) 128
12. Hsieh H.F., and Shannon S.E. Three approaches to qualitative content analysis. Qual Health Res 15 (2005) 1277-1288
13. Mayring P. Qualitative content analysis. Forum: Qual Soc Res (2000) 1
14. Meyer B.J.F. Text coherence and readability. Topics Lang Disord 23 (2003) 204-224
15. Appelbaum P.S., Roth L.H., and Lidz C. The therapeutic misconception: informed consent in psychiatric research. Int J Law Psychiatry 5 (1982) 319-329
16. Henderson G.E., Churchill L.R., Davis A.M., Easter M.M., Grady C., Joffe S., et al. Clinical trials and medical care: defining the therapeutic misconception. PLoS Med 4 (2007) e324
17. Kass N.E., Sugarman J., Faden R., and Schoch-Spana M. Trust, the fragile foundation of contemporary biomedical research. Hastings Cent Rep 26 (1996) 25-29
18. Featherstone K., and Donovan J.L. "Why don't they just tell me straight, why allocate it?" The struggle to make sense of participating in a randomised controlled trial. Soc Sci Med 55 (2002) 709-719
19. Schaeffer M.H., Krantz D.S., Wichman A., Masur H., and Reed E. The impact of disease severity on the informed consent process in clinical research. Am J Med 100 (1996) 261-268
20. Joffe S., Cook E.F., Cleary P.D., Clark J.W., and Weeks J.C. Quality of informed consent: a new measure of understanding among research subjects. J Natl Cancer Inst 93 (2001) 139-147